Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. Gains 11%; BSE HEALTHCARE Index Up 0.7%
Fri, 20 Sep 13:4

MARKSANS PHARMA. Gains 11%; BSE HEALTHCARE Index Up 0.7%Image source: Sefa Ozel/www.istockphoto.com

MARKSANS PHARMA. share price has zoomed 11% and is presently trading at Rs 304.7.

Meanwhile, the BSE HEALTHCARE index is at 43,951.7 (up 0.7%).

Among the top gainers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (up 4.1%) and FDC (up 3.0%).

POLY MEDICURE (down 2.9%) and ERIS LIFESCIENCES (down 1.9%) are among the top losers today.

Over the last one year, MARKSANS PHARMA. has moved up from Rs 101.6 to Rs 304.7, registering a gain of Rs 203.1 (up 200.0%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,951.7, registering a gain of 54.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 170.9%), SUVEN PHARMACEUTICALS (up 117.7%) and Glenmark Pharma (up 93.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 84,410.4 (up 1.5%).

The top gainers among the BSE Sensex today are M&M (up 4.9%) and JSW Steel (up 3.7%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 25,768.5 (up 1.4%). M&M and JSW Steel are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 84,410.4, registering a gain of 16,813.5 points (up 24.9%).

MARKSANS PHARMA. Financial Update...

MARKSANS PHARMA. net profit grew 26.4% YoY to Rs 891 million for the quarter ended June 2024, compared to a profit of Rs 704 million a year ago. Net sales rose 18.1% to Rs 5,906 million during the period as against Rs 5,000 million in April-June 2023.

For the year ended March 2024, MARKSANS PHARMA. reported 18.7% increase in net profit to Rs 3,149 million compared to net profit of Rs 2,653 million during FY23. Revenue of the company grew 17.6% to Rs 21,774 million during FY24.

The current Price to earnings ratio of MARKSANS PHARMA., based on rolling 12 month earnings, stands at 41.4.


Equitymaster requests your view! Post a comment on "MARKSANS PHARMA. Gains 11%; BSE HEALTHCARE Index Up 0.7%". Click here!